Portage Biotech Aktie
WKN DE: A40HBS / ISIN: VGG7185A1369
|
24.10.2025 14:34:16
|
AlphaTON Capital Appoints Wes Levitt As New CFO
(RTTNews) - AlphaTON Capital Corp. (ATON), Friday announced the appointment of Wes Levitt as Chief Financial Officer, effective immediately.
In an earlier press release, the company has stated that Levitt will succeed Andrea Park, who will depart from the company on the same day.
Most recently, Levitt served as Co-CIO at Alpha Sigma Capital Advisors.
In this latest role, he will oversee the firm's finance, accounting, and capital markets operations while supporting strategic initiatives of the company.
CEO Brittany Kaiser commented, "His deep financial leadership, capital markets expertise, and proven strategic vision will be invaluable as we strengthen our position as a leading force in the TON ecosystem and digital asset markets."
In the pre-market hours, ATON is trading at $5.23, up 2.10 percent on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Portage Biotechmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Portage Biotechmehr Analysen
Aktien in diesem Artikel
| Portage Biotech | 5,13 | 0,20% |
|